If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Trading Update

30 May 2019 07:00

RNS Number : 5394A
Plutus PowerGen PLC
30 May 2019
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Plutus PowerGen Plc / Ticker: PPG / Index: AIM

30 May 2019

PLUTUS POWERGEN PLC

("Plutus", the "Group" or the "Company")

 

Trading Update

 

Plutus PowerGen (AIM: PPG), the AIM listed power company focused on the development and operation of flexible energy generation ("FlexGen") projects in the UK, is pleased to provide an update on corporate and operational activities across its portfolio.

 

Highlights and trading update

 

· Six 20MW Rockpool funded sites, in which Plutus has a 44.5% carried interest, generated approximately £1.9m EBITDA (unaudited) for the 11 months ended 31 March 2019. This is before Capacity Mechanism ("CM") receipts which are expected to average circa £3m per annum from 2020 onwards, index linked, for the six operating companies when received (further details provided below)

· Gas site being developed with Rockpool proceeding

· Assembling gas site portfolio - two 20MW sites in planning with additional sites in the pipeline

· Appointed DWPF Ltd ("DWPF") as formal intermediary to assist in securing the equity portion within Special Project Vehicles ("SPVs") for the contemplated gas site portfolio

· Plutus trading in line with management expectations with small operating loss anticipated for the year ended 30 April 2019 and break even in the year ending 30 April 2020 before financing costs for the new gas sites

· Cash at 30 April 2019 was £64,105 (31 October 2018: £63,000) principally due to the £500,000 gross raised in mid-November much of which has been disbursed on site development. Certain management fees are being accrued due to the delay in CM payments and the temporary suspension of the CM market pending resolution of certain reviews, although auctions are still taking place. The government continues to support the CM. Accordingly, the directors are matching these accruals with regard to their directors' fees to maintain a cash flow equilibrium and therefore the directors are confident that they have sufficient resources under the current cash burn to implement their current plans.

 

The appointment of DWPF, as its formal intermediary to assist it in securing the equity portion within SPVs for the contemplated gas site portfolio, is a positive move for Plutus. DWPF are specialists in structuring and arranging projects as well as securing infrastructure finance for substantial civil/energy/infrastructure projects across the UK, DWPF have previously raised over £6 billion of funding in over 130 completed transactions. DWPF has already received interest in the approximate 70% of complementary asset financing required and is in positive discussions with several parties regarding the more challenging equity portion. Whilst there can be no guarantee that either or both of the required equity and asset financing can be obtained at a commercially acceptable rate, the Board are pleased with the non-binding indications of interest received to date.

 

Plutus' acting CEO James Longley said, "I am very pleased with recent developments as we focus on creating a portfolio of profitable operations within the robust flexible energy sector. Most notably, the agreement with DWPF to secure the equity portion for our planned gas site portfolio will enable us to implement our strategy in a timely manner and achieve Group break even in the year to 30 April 2020. The CM reviews are frustrating but are largely out of our hands and we look forward to their reinstatement. I look forward to providing our shareholders with further updates in due course."

 

**ENDS**

 

For further information, please visit www.plutuspowergen.com, or contact:

 

James Longley

Plutus PowerGen Plc

Tel: +44 (0) 20 8720 6562

David Foreman

Cantor Fitzgerald Europe

Tel: +44 (0) 207 894 7000

Richard Salmond

Cantor Fitzgerald Europe

Tel: +44 (0) 207 894 7000

Andy Thacker

Turner Pope

Tel: +44 (0) 20 3621 4120

Isabel de Salis

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFIFEAIAFIA
Date   Source Headline
15th Oct 20121:00 pmRNSDisposal
10th Oct 20127:30 amRNSStatement re. Suspension
10th Oct 20127:30 amRNSSuspension - IPSO Ventures Plc
29th Aug 20127:00 amRNSHolding(s) in Company
10th Aug 20127:00 amRNSDirector/PDMR Shareholding
3rd Aug 201212:40 pmRNSReplacement - Director Shareholding
3rd Aug 20127:00 amRNSDirector/PDMR Shareholding
15th Jun 20127:00 amRNSHolding(s) in Company
18th Apr 20127:00 amRNSDirector/PDMR Shareholding
29th Feb 20127:00 amRNSTotal Voting Rights
8th Feb 20127:00 amRNSIssue of equity, directors' shareholdings and TVR
23rd Jan 20127:01 amRNSHalf Yearly Report
17th Jan 20124:30 pmRNSHolding(s) in Company
30th Nov 20117:00 amRNSTotal Voting Rights
18th Nov 20117:00 amRNSIssue of Equity
14th Nov 20112:00 pmRNSDirector/PDMR Shareholding
1st Nov 20114:20 pmRNSChange of Registered Office
24th Oct 20117:00 amRNSAIM Rule 17 Disclosures
12th Oct 20117:00 amRNSIPSol Energy successful fund raising
3rd Oct 20115:15 pmRNSHolding(s) in Company
30th Sep 201110:00 amRNSTotal Voting Rights
30th Sep 20119:00 amRNSHolding(s) in Company
22nd Sep 20111:50 pmRNSHolding(s) in Company
15th Sep 20112:15 pmRNSEU grants approval for Buccolam
9th Sep 20111:00 pmRNSResult of AGM
25th Aug 20111:35 pmRNSIssue of Equity and Director Dealings
19th Aug 20117:00 amRNSFinal Results
8th Aug 20117:00 amRNSDirectorate Changes
12th Jul 20117:00 amRNSTermination of Loughborough University agreement
7th Jul 201110:35 amRNSCompletion of placing to raise £195,000
1st Jul 20117:00 amRNSTherakind Product Update
29th Jun 20111:05 pmRNSResult of General Meeting
27th Jun 20117:00 amRNSFurther re General Meeting
24th Jun 20117:00 amRNSHolding(s) in Company
22nd Jun 20114:58 pmRNSHolding(s) in Company
22nd Jun 20117:00 amRNSShareholding in Biocroi
13th Jun 20113:50 pmRNSProposed Placing to raise £195,000/Notice of GM
25th May 20115:10 pmRNSHolding(s) in Company
24th May 20117:00 amRNSCambridge Meditech agreement with Lantor (UK)
25th Mar 20117:00 amRNSTrading update
11th Feb 20117:00 amRNSHolding(s) in Company
8th Feb 20111:30 pmRNSHolding(s) in Company
26th Jan 20113:30 pmRNSHolding(s) in Company
5th Jan 20117:00 amRNSHalf Yearly Report
8th Oct 20103:15 pmRNSDirector/PDMR Shareholding
8th Oct 20108:00 amRNSDirectorate Change
13th Sep 20107:00 amRNSAllotment of Adviser Shares
10th Sep 201012:30 pmRNSResult of AGM
27th Aug 201012:20 pmRNSResult of General Meeting
20th Aug 20107:00 amRNSPosting of Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.